ZhangMorgan Stanley Wealth ManagementMenlo ParkCalifornia - Northern CA (Private Wealth)$2M$1.2B$10-100M$2-10MProfile SpotlightBrett BerryJ.P
Wegovy's manufacturer, Novo Nordisk, said that treatment decisions should be made together with a healthcare provider and that "side effects should be taken into account as part of this"
The most common side effects include: Loss of appetite Nausea Vomiting Diarrhea Other side effects can include: Dizziness Increased heart rate Infections Headaches Upset stomach Although rare, there are some serious side effects, including: Pancreatitis (inflammation of the pancreas) Medullary thyroid cancer Kidney injury Worsening diabetes-related retinopathy (eye disease) What are the risks
It is which option makes it easier to stay consistent on a GLP-1 and that is where MeAgain is built to win
Compound profile Semaglutide: compound profile, literature landscape and handling notes Semaglutide in one paragraph Semaglutide is a synthetic analog of human glucagon-like peptide-1 engineered for protease resistance and albumin binding, and it is the most extensively documented single-receptor incretin agonist in the published literature